Zynex Medical

Colorado just invested another $5 MILLION to strengthen the state’s #opioid recovery infrastructure — part of the $871M secured from lawsuits against opioid manufacturers and distributors. 🏥 These funds are going directly into 12 projects across the state, including: 🔹 New treatment facilities and recovery homes 🔹 Mobile harm reduction units reaching rural areas 🔹 Recovery-focused high schools for teens 🔹 Sober living housing and jail-based peer support 🔹 Investments in job readiness for those in recovery 📍 Southeast Colorado received two major awards: ➡️ $500K for Fort Lyon’s residential recovery campus ➡️ $495K to expand Lamar’s intensive outpatient and sober living services “This is about building real, long-term solutions,” said AG Phil Weiser. “We’re holding companies accountable and empowering local leaders to save lives.” 📊 Learn more at the Colorado Opioid Settlement Dashboard: 🔗 https://coag.gov/opioids #EndOverdose #OpioidCrisis #ColoradoRecovery #HarmReduction #TreatmentWorks #OpioidSettlement #OnePillCanKill #PublicHealth #RecoveryIsPossible

👶💔 Every year, about 20,000 babies in the U.S. are born with Neonatal Opioid Withdrawal Syndrome (NOWS) — a heartbreaking consequence of the opioid crisis. New research from Thomas Jefferson University offers hope: scientists found that ondansetron, a medication often used safely for nausea, may significantly reduce withdrawal symptoms in newborns. With promising results and advanced dosing models, future clinical trials aim to shorten hospital stays and improve care for these vulnerable infants. A brighter future for the tiniest victims of the opioid epidemic is on the horizon. 🌟 Read the entire article here to learn more: https://lnkd.in/gnyu6gxk #OpioidCrisis #HopeForBabies #NOWS #MedicalResearch #NeonatalCare

Just Getting Started: Thomas Sandgaard’s 29-Year Climb with Zynex Medical By the time Thomas Sandgaard landed in the U.S., he’d already helped develop the world’s first in-ear hearing aid, negotiated internationally for Philips, and led global sales teams at ITT. But none of that prepared him for starting over in the U.S., broke, renting a room, and commuting in a $1,000 Ford Probe—betting everything on a medical device startup with no safety net. Zynex Inc. began with nothing but Sandgaard’s conviction and his refusal to quit. What started as a solo effort—traveling cross-country to pitch clinics and distributors himself—has grown into a publicly traded company with nearly 1,200 employees. Its FDA-cleared electrotherapy and monitoring devices help patients manage pain, recover from strokes, and track vital signs, often as alternatives to addictive opioids. Sandgaard’s resilience wasn’t forged in Silicon Valley—it came from decades of reinvention. He was a teen inventor, a track star, a guitarist, a recording engineer, and later a rising executive across Europe’s tech and telecom giants. But it was his decision to uproot and bootstrap a business in the U.S. that pushed him to the brink—and ultimately, toward a breakthrough. For more than 20 years, he stayed personally bankrupt, often a step away from missing payroll. “I had to learn to become an entrepreneur,” he said. “I’d never even flown coach before.” In Zynex’s early years, he did it all—pitching clinics, setting up distributors, and navigating every rejection himself. When a partner backed out, he began designing Zynex’s devices in-house. When he finally hired a sales team, he made sure their incentives aligned with long-term success, not short-term deals. Today, nearly all of Zynex’s products are internally developed and FDA-cleared, and the company has scaled profitably. Now in its 29th year, Zynex reflects Sandgaard’s conviction, strategy, and sense of purpose. And despite everything he’s built—nearly three decades of growth, a Nasdaq listing, and a philanthropic foundation—he still says, “I’m just getting started.” That forward drive fuels his other ventures, too. At the Sandgaard Foundation, he’s helped distribute over a million doses of Narcan and naloxone and funded recovery efforts across the country. The Foundation also produced Junction, a feature film aimed at raising awareness about the opioid crisis. Through Sandgaard Capital, his family office, he invests in alternative assets and emerging businesses. And when he’s not working, he’s still playing lead guitar—sharing a stage with Robert Mason of Warrant and Rich Ross of the Freddy Jones Band. Legacy, he says, isn’t on his mind. “For some people in my position, legacy is a big thing. But I’ll think about it tomorrow.”

Using AI to Save Lives from Opioid Overdoses! 🚑🤖 Shoutout to Kenan Zamore for winning an APHA grant to fight opioid deaths with machine learning! 🏆📊 Right now, it can take up to 90 days to confirm if a death was drug-related — way too slow to stop more overdoses. ⏳😔 Kenan's project taps into 911 calls, EMS records, and forensic data to detect overdose spikes faster — getting life-saving resources where they’re needed, before it's too late. 🚨❤️🩹 🙌 Innovation like this will help communities act quickly, save lives, and fight the fentanyl crisis head-on. 📖 Full story here: https://lnkd.in/dpy-hmhg #OpioidCrisis #EndOverdose #PublicHealth #AIforGood #HarmReduction #Innovation #SaveLives #DataSavesLives

💸 The Trillion-Dollar Toll of the Opioid Crisis in the United States. The U.S. opioid epidemic isn't just a public health emergency — it's an economic disaster too. 📊 In 2020 alone, the crisis cost our nation $1.5 TRILLION, up 37% from 2017 (U.S. Congress Joint Economic Committee). Here’s where that money goes: 🩺 Healthcare – Skyrocketing costs from ER visits, treatment, and emergency response 📉 Lost Productivity – Absenteeism and deaths shrinking the workforce 🚔 Criminal Justice – Law enforcement, courts, and incarceration expenses 👨👩👧 Social Services – Child welfare and community support systems stretched thin. The financial fallout is massive, and it continues to grow. Tackling the opioid crisis is not just a moral issue — it's an economic imperative. 💔💰 #OpioidCrisis #EconomicImpact #PublicHealth #Awareness #RecoveryMatters